Literature DB >> 3257458

Bovine pan T-cell monoclonal antibodies reactive with a molecule similar to CD2.

W C Davis1, J A Ellis, N D MacHugh, C L Baldwin.   

Abstract

Monoclonal antibodies (mAb) CH128A and CH61A react with molecules of 50,000-60,000 MW. They are expressed by all T cells in cattle, comprising 44-69% of peripheral blood mononuclear leucocytes (PBM), the majority of lymphocytes in T-dependent areas of lymph node, and 75-80% of cells derived from the thymus including both cortical and medullary thymocytes. The molecule recognized by these mAbs is not expressed on B lymphocytes, monocytes/macrophages, or granulocytes. Both mAb inhibit spontaneous rosette formation by sheep erythrocytes and bovine lymphocytes. We postulate that these mAb see the bovine homologue of the human sheep red blood cell receptor CD2 and has been named BoT2.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3257458      PMCID: PMC1454687     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  13 in total

1.  Monoclonal antibodies identify phenotypically and functionally distinct cell types in the bovine lymphoid system.

Authors:  P A Lalor; W I Morrison; B M Goddeeris; R M Jack; S J Black
Journal:  Vet Immunol Immunopathol       Date:  1986-09       Impact factor: 2.046

2.  Production and characterization of a bovine T cell-specific monoclonal antibody identifying a mature differentiation antigen.

Authors:  E D Rabinovsky; T J Yang
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

3.  Characterization of a subset of bovine T lymphocytes that express BoT4 by monoclonal antibodies and function: similarity to lymphocytes defined by human T4 and murine L3T4.

Authors:  C L Baldwin; A J Teale; J G Naessens; B M Goddeeris; N D MacHugh; W I Morrison
Journal:  J Immunol       Date:  1986-06-15       Impact factor: 5.422

4.  Increased spontaneous erythrocyte rosette formation of feline lymphocytes preincubated at 37 degrees C.

Authors:  G L Cockerell; C L Baldwin
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

5.  Rosette-formation between human lymphocytes and sheep red cells not involving immunoglobulin receptors.

Authors:  R R Coombs; B W Gurner; A B Wilson; G Holm; B Lindgren
Journal:  Int Arch Allergy Appl Immunol       Date:  1970

6.  Non-immune erythrocyte rosette formation of bovine peripheral blood and thymus lymphocytes.

Authors:  H W Renshaw
Journal:  Comp Immunol Microbiol Infect Dis       Date:  1981       Impact factor: 2.268

7.  Identification of surface proteins on bovine leukocytes by a biotin-avidin protein blotting technique.

Authors:  W L Hurley; E Finkelstein; B D Holst
Journal:  J Immunol Methods       Date:  1985-12-17       Impact factor: 2.303

8.  Lymphocyte surface markers in sheep blood and lymph.

Authors:  P M Outteridge; K J Fahey; C S Lee
Journal:  Aust J Exp Biol Med Sci       Date:  1981-04

9.  Enumeration of T cells, B cells and monocytes in the peripheral blood of normal and lymphocytotic cattle.

Authors:  P S Paul; D R Senogles; C C Muscoplat; D W Johnson
Journal:  Clin Exp Immunol       Date:  1979-02       Impact factor: 4.330

10.  Identification of a human T lymphocyte surface protein associated with the E-rosette receptor.

Authors:  M Kamoun; P J Martin; J A Hansen; M A Brown; A W Siadak; R C Nowinski
Journal:  J Exp Med       Date:  1981-01-01       Impact factor: 14.307

View more
  12 in total

1.  Bovine gammadelta T-cell responses to the intracellular protozoan parasite Theileria parva.

Authors:  C A Daubenberger; E L Taracha; L Gaidulis; W C Davis; D J McKeever
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Identification and phenotyping of leukocytes in bovine bronchoalveolar lavage fluid.

Authors:  E C Soethout; K E Müller; A J M van den Belt; V P M G Rutten
Journal:  Clin Diagn Lab Immunol       Date:  2004-07

3.  Biochemical and functional characterization of 8-10C5 (gp120,90), a novel molecule on the surface of bovine T leucocytes.

Authors:  K L O'Reilly; G A Splitter
Journal:  Immunology       Date:  1990-11       Impact factor: 7.397

4.  Characterization of a bovine leucocyte differentiation antigen of 145,000 MW restricted to B lymphocytes.

Authors:  J Naessens; J Newson; N McHugh; C J Howard; K Parsons; B Jones
Journal:  Immunology       Date:  1990-04       Impact factor: 7.397

5.  Monoclonal antibodies to ovine SBU-T8 and SBU-T6 bind analogous molecules on bovine lymphocytes.

Authors:  K L O'Reilly; G A Splitter
Journal:  Immunology       Date:  1989-06       Impact factor: 7.397

6.  Clinical and immunological effects of single bolus administration of recombinant interleukin-2 in cattle.

Authors:  M Campos; H P Hughes; D L Godson; L M Sordillo; A Rossi-Campos; L A Babiuk
Journal:  Can J Vet Res       Date:  1992-01       Impact factor: 1.310

7.  Identification of two distinct subsets of bovine gamma delta T cells with unique cell surface phenotype and tissue distribution.

Authors:  N D Machugh; J K Mburu; M J Carol; C R Wyatt; J A Orden; W C Davis
Journal:  Immunology       Date:  1997-11       Impact factor: 7.397

8.  Local interleukin-2 therapy in bovine ocular squamous cell carcinoma. A pilot study.

Authors:  V P Rutten; W R Klein; W A De Jong; W Misdorp; W Den Otter; P A Steerenberg; W H De Jong; E J Ruitenberg
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

9.  Progressive bovine paratuberculosis is associated with local loss of CD4(+) T cells, increased frequency of gamma delta T cells, and related changes in T-cell function.

Authors:  Ad Koets; Victor Rutten; Aad Hoek; Frans van Mil; Kerstin Müller; Douwe Bakker; Erik Gruys; Willem van Eden
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

10.  Strain specificity of bovine Theileria parva-specific cytotoxic T cells is determined by the phenotype of the restricting class I MHC.

Authors:  B M Goddeeris; W I Morrison; P G Toye; R Bishop
Journal:  Immunology       Date:  1990-01       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.